Discover
Stocks
Consumer Goods
RETA
RETA
Reata Pharmaceuticals Inc
171.75
-0.25
(
-0.14%
)
Market Open
Delayed Prices By NASDAQ,
in USD
Trade
Buy
RETA
Reata Pharmaceuticals Inc
Overview
Chart
Analysis
News
Stats
Trade
Buy
FINANCIAL SUMMARY
For the fiscal year ended 31/12/2022: Reata Pharmaceuticals Inc's revenues decreased by 80.71% and amounted to 2.22M. Net income decreased by 4.88% to -311.90M. Net assets decreased by 135.32% to -65.70M and EPS decreased from -8.19 to -8.54.
RETA's Investor Relations
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
91.58%
Net Profit Margin
-4,130.95%
Operating Margin
-1,455.08%
Return On Investment
-58.18%